Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.

Molecular aspects of medicine - 1 Nov 2015

Harris Wayne B

Abstract excerpt

The bulk of the literature on kidney cancer in African Americans comes from population-based studies of incidence and survival over varying periods of time using databases from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI). The purpose of this review is to summarize the literature on racial disparities in clinical outcome in patients with renal cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Black or African American
Share to Carcinoma, Renal Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenomics

Share to Health Status Disparities

Share to Incidence

Share to Meta-Analysis as Topic

Share to Risk Assessment

Source

Identifiers

PMID: 26071853
DOI: 10.1016/j.mam.2015.06.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers for evaluating racial disparities in clinical outcome in patients with renal cell carcinoma.PMID 26071853Read ↗

Molecular biomarkers in advanced renal cell carcinoma.Semantic proximity Read ↗

Renal cell cancer among African Americans: an epidemiologic review.Semantic proximity Read ↗

Biomarkers of renal cell carcinomaSemantic proximity Read ↗

Molecular markers to predict response to therapy.Semantic proximity Read ↗

Prognostic and predictive biomarkers in renal cell carcinoma.Semantic proximity Read ↗

[Biomarkers of response to molecular targeted therapy in renal cell carcinoma].Semantic proximity Read ↗

Epidermal growth factor as a prognostic biomarker in chronic kidney diseasesSemantic proximity Read ↗

A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.Semantic proximity Read ↗

Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.Semantic proximity Read ↗

Disparities in the burden, outcomes, and care of chronic kidney disease.Semantic proximity Read ↗

Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.Semantic proximity Read ↗

Racial Differences in Oxidative Stress and Inflammation: In Vitro and In VivoSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.